1. Home
  2. USNA vs MRVI Comparison

USNA vs MRVI Comparison

Compare USNA & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

HOLD

Current Price

$21.43

Market Cap

396.3M

Sector

Health Care

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.12

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USNA
MRVI
Founded
1992
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
396.3M
472.8M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
USNA
MRVI
Price
$21.43
$3.12
Analyst Decision
Hold
Buy
Analyst Count
1
7
Target Price
$36.00
$4.57
AVG Volume (30 Days)
112.4K
1.1M
Earning Date
02-17-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$912,670,000.00
$192,435,000.00
Revenue This Year
$10.42
N/A
Revenue Next Year
$3.37
$10.00
P/E Ratio
$23.59
N/A
Revenue Growth
5.88
N/A
52 Week Low
$18.48
$1.67
52 Week High
$38.32
$4.77

Technical Indicators

Market Signals
Indicator
USNA
MRVI
Relative Strength Index (RSI) 54.48 34.58
Support Level $20.57 $3.06
Resistance Level $21.98 $3.51
Average True Range (ATR) 0.79 0.18
MACD -0.10 -0.06
Stochastic Oscillator 47.74 5.35

Price Performance

Historical Comparison
USNA
MRVI

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: